These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17916461

  • 21. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
    Bickers B, Aukim-Hastie C.
    Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
    [Abstract] [Full Text] [Related]

  • 22. New circulating biomarkers for prostate cancer.
    Bensalah K, Lotan Y, Karam JA, Shariat SF.
    Prostate Cancer Prostatic Dis; 2008 Aug; 11(2):112-20. PubMed ID: 17998918
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L, Lind MJ, Welham KJ, Cawkwell L, Cancer Biology Proteomics Group.
    Cancer; 2006 Jul 15; 107(2):232-41. PubMed ID: 16752413
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Urinary markers for prostate cancer.
    Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW.
    BJU Int; 2007 Feb 15; 99(2):263-8. PubMed ID: 17092277
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical proteomics and biomarker discovery.
    Johann DJ, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA.
    Ann N Y Acad Sci; 2004 Jun 15; 1022():295-305. PubMed ID: 15251975
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH, Levy S, Chaurand P, Carbone DP.
    Crit Rev Oncol Hematol; 2007 Jan 15; 61(1):1-25. PubMed ID: 17015021
    [Abstract] [Full Text] [Related]

  • 38. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A, Jurisica I, Kislinger T.
    Expert Rev Proteomics; 2008 Aug 15; 5(4):551-60. PubMed ID: 18761466
    [Abstract] [Full Text] [Related]

  • 39. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
    Shariat SF, Karam JA, Margulis V, Karakiewicz PI.
    BJU Int; 2008 Mar 15; 101(6):675-83. PubMed ID: 17941930
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.